Healthcare

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial…

6 months ago

Biotricity Announces Accelerated Path to EBITDA Positive

REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the…

6 months ago

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in…

6 months ago

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-CalMALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE)…

6 months ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on…

6 months ago

Fortrea Appoints Robert Parks as Chief Accounting Officer

DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced…

6 months ago

3Daughters Secures $4.7 Million in Oversubscribed Seed Round

Funds will support development of game-changing IUD (intrauterine device) for contraception through an IND filing in early 2025MANSFIELD, Mass., July…

6 months ago

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic…

6 months ago

Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024

ORANGE, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2024 financial…

6 months ago

Samsung Bioepis Releases Third Quarter 2024 US Biosimilar Market Report

Addresses frequently asked questions on biosimilar interchangeability and its exclusivity Includes an interview with Scripius’ pharmacy benefit manager on their…

6 months ago